| Product Code: ETC7632976 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to see a high concentration of large molecule drug substance CDMO import shipments, with the top exporting countries being the USA, UK, Germany, Metropolitan France, and Serbia. Despite a negative compound annual growth rate (CAGR) of -4.18% from 2020 to 2024 and a steep decline in growth rate from 2023 to 2024 at -30.16%, the market remained competitive with a very high concentration as measured by the Herfindahl-Hirschman Index (HHI). This indicates a steady flow of imports in the sector, with key players maintaining a strong presence in the Irish market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Large Molecule Drug Substance CDMO Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Ireland Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Ireland Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drug development services |
4.2.2 Growth in biopharmaceutical research and development activities in Ireland |
4.2.3 Favorable government initiatives and policies supporting the biopharmaceutical industry |
4.3 Market Restraints |
4.3.1 Intense competition from other global CDMOs |
4.3.2 Regulatory challenges and compliance requirements in the biopharmaceutical sector |
5 Ireland Large Molecule Drug Substance CDMO Market Trends |
6 Ireland Large Molecule Drug Substance CDMO Market, By Types |
6.1 Ireland Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Ireland Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Ireland Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Ireland Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Ireland Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage of repeat business from existing clients |
8.2 Number of new partnerships and collaborations formed |
8.3 Average project turnaround time for large molecule drug substance development |
9 Ireland Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Ireland Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Ireland Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Ireland Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Ireland Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Ireland Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Ireland Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |